About this trial
The Achilles tendon is the strongest and largest tendon in the human body, playing a critical role in plantarflexion and facilitating activities such as walking, running, and jumping. However, it is also the most frequently ruptured tendon. The injury and associated disability have a significant impact on patient quality of life and healthcare services. Achilles tendon ruptures are increasingly common, particularly among middle-aged recreational athletes, with an incidence estimated at 18 per 100,000 person-years.
The Swansea Morriston Achilles Rupture Treatment (SMART) protocol represents a structured, progressive approach to non-operative rehabilitation. It emphasizes early mobilization, protected weight-bearing, and a gradual return to sport or high-level function through targeted strength and neuromuscular training. While short-term outcomes of non-surgical protocols have demonstrated promising results, there remains limited high-quality data on long-term isokinetic strength and patient-reported functional outcomes beyond six months in this patient group.
This study aims to evaluate isokinetic plantarflexor strength and self-reported functional outcomes at 12 months following non-surgical management of Achilles tendon ruptures using the SMART rehabilitation protocol. By assessing both objective and subjective recovery metrics, we aim to contribute to the growing evidence base for evidence-informed, conservative Achilles tendon rehabilitation. A secondary aim of the study is to examine the relationship between isokinetic strength scores and self reported functional recovery scores using the ATRS questionnaire.
Participants will attend one 60-90 minute visit to complete a short questionnaire and perform a safe, clinic-based ankle strength test using an isokinetic machine; the test feels like pushing against a footplate, similar to resisted ankle movements. The results of these tests will be collected and analysed. The study will help to gain further insight into patient recovery from this injury.
Eligibility criteria
Qualifiers
Adults aged 18 years or older at the time of recruitment.
Confirmed diagnosis of Achilles tendon rupture, diagnosed clinically and recorded within the NHS database.
Injury managed non-surgically using the SMART (Swansea Morriston Achilles Rupture Treatment) protocol.
12-15 months post-injury at the time of assessment.
Disqualifiers
Unable to provide informed consent.
Previous surgical repair of the Achilles tendon or documented re-rupture.
Presence of a neuromuscular disorder affecting lower limb strength or function.
Did not follow the SMART protocol for non-surgical management.
Trial design
Treatments tested in this trial
- Non-Surgical Management Using the SMART Protocol